GC Therapeutics Expands Leadership Team with Industry Veterans Kai-Hsin Chang and Azadeh Golipour [Yahoo! Finance]
Tectonic Therapeutic, Inc. (TECX)
Company Research
Source: Yahoo! Finance
cell therapies, today announced the appointment of two industry leaders to its executive team. Kai-Hsin Chang, Ph.D., is a former drug development leader at Editas, and will serve as Head of Drug Development, SVP and Azadeh Golipour, Ph.D., is a tech ops veteran previously at AVROBIO joining as Head of Technical Operations, SVP. Dr. Chang brings a wealth of expertise in drug development, regulatory strategy, and translational medicine from her tenure at Editas Medicine, where she played a key role in advancing genome-editing therapies through critical preclinical and clinical stages with multiple successful INDs. Her extensive background will significantly strengthen GC Therapeutics' strategic and operational capabilities in drug development, accelerating the company's journey toward delivering life-changing treatments. "I am excited to join GC Therapeutics at such a transformative stage," said Dr. Chang. "GCTx's cutting-edge approach, particularly its innovative TFome™ platform,
Show less
Read more
Impact Snapshot
Event Time:
TECX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECX alerts
High impacting Tectonic Therapeutic, Inc. news events
Weekly update
A roundup of the hottest topics
TECX
News
- Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating [Yahoo! Finance]Yahoo! Finance
- Tectonic Therapeutic to Participate in December Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Tectonic Therapeutic to Participate in December Investor ConferencesGlobeNewswire
- Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point [Seeking Alpha]Seeking Alpha
- Tectonic Therapeutic GAAP EPS of -$1.02 beats by $0.05 [Seeking Alpha]Seeking Alpha
TECX
Earnings
- 11/6/25 - Beat
TECX
Analyst Actions
- 10/20/25 - Wells Fargo & Company
TECX
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- TECX's page on the SEC website